Building resilience into your organization

The second installment in our Resilient Mindset Mini-Series is focused on how to build resilience into the organizational foundations of your business by considering your leadership, strategic and systemic resilience in the face of pressure from external forces.
In this edition of our short video series, CEO of Zuellig Pharma, John Davison, reflects on how the organization’s resilience and digital transformation were developed. In conversation with Katherina Lange Professor of Leadership at IMD and Tawfik Jelassi, Professor of Strategy & Technology Management also at IMD, he credits that effort as key to Zuellig Pharma’s navigation of the COVID-19 crisis.
Zuellig Pharma’s success during the COVID-19 outbreak has been based on the strength of its Business Continuity Plan (BCP), its supply chain resilience and the organizational commitment of its people to make healthcare accessible. Davison describes the central importance of the BCP and also outlines Zuellig Pharma’s successful transformation from traditional pharmaceutical wholesaler to modern, data driven healthcare service provider.
Other topics raised in the discussion include the reinvention of Zuellig Pharma over the past five years to provide a new foundational support to the business’s ability to not only meet, but to gain momentum through challenging times. By developing new business streams, the company effectively future-proofed itself.
Davison describes Zuellig Pharma’s investment in technology across its business model, the restructuring of the organization to ensure optimal balance between centralized and decentralized decision-making, and the opportunities Zuellig Pharma has been able to seize during the crisis.
“We build resilience into our organization, systems and supply chain because, as a distribution company in the healthcare space, we cannot afford to step down. We have to keep supplying; we have to keep delivering. If we stopped doing that, we would no longer be true to our mission of making healthcare accessible.” – CEO of Zuellig Pharma, John Davison.
Research Information & Knowledge Hub for additional information on IMD publications
The case study explores the second phase of ABB's 2018 to 2024 transformation journey to restore confidence in the underperforming conglomerate through a simplification of its structure and a focus on accelerating decision making. Under interim CE...
The case study explores the first phase of ABB's 2018 to 2024 transformation journey as it tackled longstanding challenges: financial underperformance, declining market confidence and inefficiencies in its complex matrix structure. To streamline o...
Recombinant innovation—the process through which atypical and unexpected combinations of knowledge generate novel outcomes—is a critical driver of organizational distinctiveness and market transformation. While prior research has focused on firm- ...
The emergence of AI agents and agentic systems represents a significant milestone in artificial intelligence, enabling autonomous systems to operate, learn, and collaborate in complex environments with minimal human intervention. This paper, drawi...
In today's workplace, the proliferation of digital technologies has transformed work tasks but also led to technostress. This stress, associated with technology use, negatively impacts employees' behavioral outcomes and performance. Despite these ...
When Tony Banet took up his new post as CEO of the North America division of Especia Hispania (the names were changed), he took over a team characterized by mistrust. There had been no CEO at for the previous six months. This management vacuum had...
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications
in Journal of Product Innovation Management 4 September 2025, ePub before print, https://doi.org/10.1111/jpim.70003
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications
in Journal of Computer Information Systems August 2025, vol. 65, no. 4, pp. 489-517, https://doi.org/10.1080/08874417.2025.2483832
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications
Case reference: IMD-7-2642 ©2025
Research Information & Knowledge Hub for additional information on IMD publications
in Technological Forecasting and Social Change July 2025, vol. 2016, 124143, https://doi.org/10.1016/j.techfore.2025.124143
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications